- Description
- Specifications
Catalog #: HIV-140
Description:
HIV-2 Envelope recombinant- composes all of the reported immunogenic determinants found in gp39. The gene encoding this fusion protein was synthesized using codons optimized for E.coli expression and doesn't represent a linear HIV-2 envelope sequence. HIV-2 is a non-glycosylated, 135 amino acids polypeptide chain, having a molecular mass of 16,127 Dalton, P.I=5.17.
Source:
Escherichia Coli.
Applications:
HIV-2 Envelope antigen in ELISA and Western blots, excellent antigen for early detection of HIV seroconvertors with minimal specificity problems.
Purity:
Greater than 95.0% as determined by HPLC analysis and SDS-PAGE.
Formulation:
50mM Tris-HCL & 6M urea, pH-7.
Stability:
HIV-2 Envelope although stable at 4 °C for 1 week, should be stored below -18 °C.
Please prevent freeze thaw cycles.
Specificity:
Immunoreactive with all sera of HIV-2 infected individuals.
Physical Appearance:
Sterile filtered colorless clear solution.
Usage:
Denovo Biotechnology's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
